SAM
EGRX

Symphony Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Symphony Asset Management’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-4,250
Closed -$253K – 383
2017
Q3 		$253K Sell
4,250
-282
-6% -$16.8K 0.03% 324
2017
Q2 		$358K Sell
4,532
-1,658
-27% -$131K 0.04% 301
2017
Q1 		$513K Buy
+6,190
New +$513K 0.05% 286